FOXP3 and cancer: As recent review reported several pathways in Treg from cancers including Foxp3, IRF4, PI3/AKT/FoxO axis, Helios, Eos, Nr4a, Bach2, E proteins and their inhibitor of DNA-binding (Id) counterparts, STAT3, and NF-kB (22).